Hedge funds could struggle to find clearing member due to regulatory uncertainty |
Date: Tuesday, June 14, 2011
Author: Charles Gubert, COO Connect
Some hedge funds could find themselves in a last minute mass scramble to find
a clearing member to deal with their over-the-counter (OTC) derivatives
transactions due to the regulatory uncertainty concerning clearing in both the
US and European Union (EU).
These delays could prove costly for asset managers. Industry experts have warned
that some fund managers might be unable to find a clearing member if they leave
the decision too late. Stuart Anderson, vice president of BlackRock Multi Asset
Client Solutions, said this could pose problems for smaller asset managers with
limited resources.
“The largest asset managers have been incredibly proactive in finding and
securing a clearing member. However, if some of the smaller asset managers leave
it too late, they might be pushed down the prime brokers’ lists of priorities.
This will make it difficult for them to get the required legal documentation in
place to meet the deadlines,” he said.
Several prime brokers have also warned that hedge funds should not procrastinate
despite the lacking clarity over the regulations.
Both the US Dodd Frank Act and the European Markets Infrastructure Regulation
(EMIR) state that financial institutions trading in OTC derivatives must clear
their trades through a central counterparty (CCP) clearing house via their prime
broker or agent bank.
However, the regulation especially in the US has been subject to delays. The
Commodities Futures Trading Commission (CFTC) is holding a public meeting on
Tuesday, June 14 to discuss implementation dates for Dodd Frank. It is expected
the CFTC will acknowledge it cannot meet the July 2011 deadlines. Meanwhile, the
European Commission (EC) is unlikely to vote on the issue until mid 2012.
In the US, Congressional Republicans have drafted legislation to delay the
implementation of OTC derivatives rules until the end of 2012. Jill Sommers, the
Republican-appointed commissioner at the CFTC recently warned there was
regulatory arbitrage between the US and EU. However, she did add that regulators
on both sides of the Atlantic were working together to iron out any differences
that may exist.
One area that may cause consternation between US and EU regulators is the EU’s
decision to give pension funds a three year reprieve on clearing their OTC
derivatives. The decision to force pension funds to clear OTC derivatives had
raised criticisms due to the costs they would have to bear for putting up cash
collateral. This was all the more galling considering these conservative
institutions mainly use OTC derivatives for hedging risk.
There are also concerns that there is regulatory arbitrage within the US between
the CFTC and the Securities and Exchange Commission (SEC). A report in April
2011 by advisory firm Aite Group said there was a lack of clarity over the
definitions and terms while jurisdictional confusion was likely to arise due to
the regulatory oversight being divided between the SEC and CFTC.
Reproduction in whole or in part without permission is prohibited.